I believe the beauty of TNFerade is its ability to work with nearly all other therapies and the fact that it may applied to far more than the few cancers it's currently in trials with. We know it works with Pancreatic, Esophageal, and Head and Neck Cancers, but what if it works with Lung, or Breast, or Colon, etc. etc.
Once we have a partner I would expect that many new trials will will be established for other cancer, but not immediately, as it takes time to develop the new protocols, but with funds no longer a problem, it should happen fully funded by our partner.
While we cannot know the earning capacity of TNFerade without further trials, it's potential is huge as it may be determined to work with many types of solid tumors.
Gary |
